The Assessment of Prednisone In Remission Trial (TAPIR)

Brief Description Of Study

The purpose of this study is to collect information about two different recommended treatments for granulomatosis with polyangiitis (GPA, Wegener’s). We want to find out whether patients with GPA do better if they stay on a maintenance dose of 5 mg of prednisone or come off of prednisone after GPA is well-controlled. Patients will be in the study for no longer than 18 months. To join this study, patients must be taking prednisone.

Clinical Study Identifier: 01933724

Detailed Study Description

There are up to five visits for this study: a screening visit, a baseline visit, a three month visit, a six month visit or a flare visit, and an 18 months after randomization encounter.

Contact research investigator to learn more about this study by filling out the form below.

To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: The Assessment of Prednisone In Remission Trial (TAPIR)
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.